Skip to main content

Candel Therapeutics, Inc.

CADL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001841387

In the last 90 days, Candel Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 137 institutions reported holding it in 13F filings for Q2 2026, worth $518.9M in total; no superinvestor holds it.

13F holders, Q2 2026

Institutional positions in Candel Therapeutics, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
137
+26 vs. Q1 2026
Shares held
50.4M
+7.14M (+16.5%) vs. Q1 2026
Total value
$518.9M
+$306.8M (+144.7%) vs. Q1 2026
New holders
39
63 more added
Sold out
13
24 more reduced

3 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2026: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting CADL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2026: 137 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 12 institutionsQ4 2021: 20 institutionsQ1 2022: 23 institutionsQ2 2022: 23 institutionsQ3 2022: 25 institutionsQ4 2022: 21 institutionsQ1 2023: 21 institutionsQ2 2023: 20 institutionsQ3 2023: 20 institutionsQ4 2023: 22 institutionsQ1 2024: 20 institutionsQ2 2024: 45 institutionsQ3 2024: 52 institutionsQ4 2024: 71 institutionsQ1 2025: 82 institutionsQ2 2025: 78 institutionsQ3 2025: 81 institutionsQ4 2025: 84 institutionsQ1 2026: 114 institutionsQ2 2026: 137 institutions
Value heldQ2 2026: $518.9M
Q1 2021: $0Q2 2021: $0Q3 2021: $52.9MQ4 2021: $54.4MQ1 2022: $34.0MQ2 2022: $20.6MQ3 2022: $19.1MQ4 2022: $9.70MQ1 2023: $7.44MQ2 2023: $6.77MQ3 2023: $4.86MQ4 2023: $5.92MQ1 2024: $5.97MQ2 2024: $37.0MQ3 2024: $46.4MQ4 2024: $155.7MQ1 2025: $119.7MQ2 2025: $116.6MQ3 2025: $115.6MQ4 2025: $133.5MQ1 2026: $212.9MQ2 2026: $518.9M
Institutions holding CADL and their total value by quarter
QuarterHoldersValue
Q2 2026137$518.9M
Q1 2026114$212.9M
Q4 202584$133.5M
Q3 202581$115.6M
Q2 202578$116.6M
Q1 202582$119.7M
Q4 202471$155.7M
Q3 202452$46.4M
Q2 202445$37.0M
Q1 202420$5.97M
Q4 202322$5.92M
Q3 202320$4.86M
Q2 202320$6.77M
Q1 202321$7.44M
Q4 202221$9.70M
Q3 202225$19.1M
Q2 202223$20.6M
Q1 202223$34.0M
Q4 202120$54.4M
Q3 202112$52.9M
Q2 20210$0
Q1 20210$0

Institutions, Q2 2026

Shares, value and share of portfolio for each institution holding Candel Therapeutics, Inc.; share changes are against Q1 2026.

Institutions holding CADL in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Rhumbline Advisers78,045$803.9K0.00%+26,646+51.8%Added
Citigroup Inc85,510$880.8K0.00%+64,128+299.9%Added
Kynam Capital Management, LP96,741$996.4K0.06%−103,259−51.6%Reduced
Ghisallo Capital Management LLC100,000$1.03M0.02%−100,000−50.0%Reduced
Trexquant Investment LP101,317$1.04M0.01%+101,317New
Jump Financial, LLC106,840$1.10M0.01%+106,840New
D. E. Shaw & Co., Inc.108,933$1.12M0.00%+108,933New
Commonwealth Equity Services, LLC115,875$1.19M0.00%+20,480+21.5%Added
Morgan Stanley126,145$1.30M0.00%+67,916+116.6%Added
Point72 Asset Management, L.P.129,183$1.33M0.00%+21,972+20.5%Added
Nuveen, LLC142,978$1.47M0.00%+49,820+53.5%Added
Citadel Advisors LLC146,016$1.50M0.00%+73,350+100.9%Added
UBS Group AG169,271$1.74M0.00%+19,416+13.0%Added
Bank of New York Mellon Corp191,701$1.97M0.00%+55,435+40.7%Added
Tanager Wealth Management LLP198,175$2.04M0.18%00.0%Unchanged
Charles Schwab Investment Management Inc199,454$2.05M0.00%+87,738+78.5%Added
Wellington Management Group LLP205,745$2.12M0.00%+205,745New
Susquehanna International Group, LLP227,939$2.35M0.00%+114,966+101.8%Added
Bank of America Corp278,944$2.87M0.00%+231,542+488.5%Added
Marshall Wace, LLP300,641$3.10M0.00%+300,641New
Goldman Sachs Group Inc305,216$3.14M0.00%+77,695+34.1%Added
Sands Capital Ventures, LLC405,837$4.18M0.68%00.0%Unchanged
Vanguard Fiduciary Trust Co412,109$4.24M0.00%+131,658+46.9%Added
Vanguard Portfolio Management LLC437,150$4.50M0.00%+168,901+63.0%Added
Kennedy Capital Management, Inc.488,291$5.03M0.09%+395,666+427.2%Added
Northern Trust Corp492,465$5.07M0.00%+169,311+52.4%Added
Halter Ferguson Financial Inc.772,461$7.96M1.30%−131,590−14.6%Reduced
Millennium Management LLC1,093,905$11.3M0.01%+33,819+3.2%Added
Geode Capital Management, LLC1,571,021$16.2M0.00%+535,586+51.7%Added
Vanguard Capital Management LLC2,694,040$27.7M0.00%+231,283+9.4%Added
Saturn V Capital Management LLC3,303,686$34.0M4.88%+407,098+14.1%Added
Portolan Capital Management, LLC3,490,398$36.0M1.35%+596,073+20.6%Added
Acorn Capital Advisors, LLC3,497,948$36.0M9.83%00.0%Unchanged
State Street Corp3,549,823$36.6M0.00%+2,731,265+333.7%Added
BlackRock, Inc.4,969,040$51.2M0.00%+1,859,998+59.8%Added
RTW Investments, LP6,422,018$66.1M0.56%00.0%Unchanged
FMR LLC10,990,535$113.2M0.00%+3,5180.0%Added
Vestal Point Capital, LP0$00.00%−1,125,000−100.0%Sold out
Heights Capital Management, Inc0$00.00%−775,000−100.0%Sold out
ExodusPoint Capital Management, LP0$00.00%−227,468−100.0%Sold out
Woodline Partners LP0$00.00%−156,700−100.0%Sold out
Stonepine Capital Management, LLC0$00.00%−102,500−100.0%Sold out
Bridgeway Capital Management, LLC0$00.00%−75,100−100.0%Sold out
HRT Financial LP0$00.00%−32,015−100.0%Sold out
Krilogy Financial LLC0$00.00%−30,065−100.0%Sold out
Taylor Financial Group, Inc.0$00.00%−16,600−100.0%Sold out
Renaissance Technologies LLC0$00.00%−12,780−100.0%Sold out
Mirabella Financial Services LLP0$00.00%−12,489−100.0%Sold out
Group One Trading, L.P.0$00.00%−8,760−100.0%Sold out
MAI Capital Management0$00.00%−39−100.0%Sold out
Janus Henderson Group PLC––––Not filed
CWM, LLC––––Not filed
Sunbelt Securities, Inc.––––Not filed